In this Section |
185971 Measuring Progress toward the HP2010 Goals: Cancer Screening in Two Chicago Asian PopulationsTuesday, October 28, 2008: 3:20 PM
Background: Cancer is one of the leading causes of death for Asian American and Pacific Islanders in the U.S., yet surveillance of cancer screening for this population at the national, state and local levels is limited and often inadequate to measure progress toward meeting the Healthy People 2010 (HP2010) Goals. We thus examined how well two Asian populations in Chicago fare in reaching these goals. Methods: A comprehensive health survey was conducted with a representative sample of Chinese (n=219) and Cambodian populations (n=150) in Chicago. Eligible participants were 18+, self-identified as AAPI and consented to the study. Surveys were conducted face-to-face in Mandarin, Cantonese, Cambodian, or English in between 2006-2008. Results: Among women age 40+, 48% of Chinese women and 63% of Cambodian women reported that they received a mammogram in the last 2 years. Neither community met the HP2010 goal of 70%. The HP2010 Goal for pap smears is that 90% of women age 18+ receive a pap within the last 3 years. Survey data found that only 40% of Chinese and 51% of Cambodian women met this goal. The HP2010 Goal for colon cancer is that 50% of adults age 50+ have ever had a sigmoidscopy/ colonscopy yet survey data indicated that only 23% of Chinese and 45% of Cambodian adults met this goal. Conclusion: We will present cancer screening rates for these AAPI populations, examine the associated social and demographic correlates, and discuss implications of these findings in meeting HP2010 goals.
Learning Objectives: Keywords: Asian and Pacific Islander, Cancer Screening
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: Responsible for initiating this effort, developing all materials, administering the research and drafting this abstract. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
See more of: Cancer Screening (e.g., Mammography, Colorectal Screening) and Prevention
See more of: Epidemiology |